Results 111 to 120 of about 4,953 (173)

Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells

Blood Advances
Dominic Pizzarella, Amanda Kofides, John M. Hatcher, Xia Liu, Alberto Guijosa, Nickolas Tsakmaklis, Abigail L. Peachey, Jinhua Wang, Maria Luisa Guerrera, Christopher J. Patterson, Zachary R. Hunter, Hao Sun, Shayna R. Sarosiek, Jorge J. Castillo, Sara J. Buhrlage, Sirano Dhe-Paganon, Andrew R. Branagan, Steven P. Treon, Shirong Liu   +18 more
doaj   +1 more source

Refining prognostic tools in Waldenström macroglobulinemia. [PDF]

Blood Adv
Lionel AC, Thomas SK.
europepmc   +1 more source

Waldenström Macroglobulinemia Presenting With Hepatic Lesions: Case Report and Literature Review. [PDF]

Case Rep Hematol
Sternbach N, Bishara S, Gertz MA, Vaxman I.   +3 more
europepmc   +1 more source

Rituximab-based treatments in Waldenström's macroglobulinemia

, 2009
The anti-CD20 monoclonal antibody rituximab has shown activity in approximately one third of patients with Waldenström's Macroglobulinemia (WM).
Migkou, M., Roussou, M., Tassidou, A., Dimopoulos, M., Eleutherakis-Papaiakovou, E., Gavriatopoulou, M., Terpos, E., Kastritis, E.   +7 more
core  

POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia. [PDF]

Blood Adv
Zanwar S, Abeykoon J, D'Sa S, Roos-Weil D, Larson DR, Colby CL, Durot E, Kastritis E, Uppal E, Tomkins O, Morel P, Mondello P, Montes L, Paludo J, Ailawadhi S, Sarosiek S, Ogunbiyi O, Cornillet-Lefebvre P, Rajkumar SV, Quinquenel A, Dispenzieri A, Fonseca R, Gertz MA, Kumar S, Dimopoulos MA, Ansell SM, Treon S, Castillo JJ, Kapoor P.   +28 more
europepmc   +1 more source

An Atypical Presentation of Ecthyma Gangrenosum in a Patient With Waldenström Macroglobulinemia. [PDF]

Cureus
Eggert-Cichocki SR, Meyer MS, Goldbaum A, Zakaria K.   +3 more
europepmc   +1 more source

CD3xCD20 bispecific antibodies in transformed Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. [PDF]

Hemasphere
Brocard M, Roos-Weil D, Kanagaratnam L, Hueso T, Bussot L, Papoular B, Tomowiak C, Chevreux S, Crochet G, Vaugeois T, Toussaint E, Ferrero S, Kyriakou C, Quinquenel A, Kapoor P, Durot E.   +15 more
europepmc   +1 more source

How I treat Waldenström macroglobulinemia

, 2019
Waldenström macroglobulinemia (WM) is an uncommon lymphoma characterized by the infiltration of the bone marrow by clonal lymphoplasmacytic cells that produce monoclonal immunoglobulin M (IgM).
Dimopoulos, M.A., Dimopoulos, Meletios A, Kastritis, E., Kastritis, Efstathios   +3 more
core  

Waldenstrom Macroglobulinemia Leading to Cholestatic Liver Injury and Rapid Progression to Liver Failure. [PDF]

ACG Case Rep J
Chi H, Kim D, Waidyaratne G, Hashi N, Sun S, Maddocks K, Kelly S.   +6 more
europepmc   +1 more source

Zanubrutinib in the treatment of Waldenström Macroglobulinemia. [PDF]

Future Oncol
Goodall E, Opat S.
europepmc   +1 more source